Study of rectal cancer patients in Austria
Part of Cancer, Digestive system clinical trials.
This study looks at adults with rectal cancer that hasn't spread, to learn more about the disease and treatments. It includes people who get a special treatment before surgery (TNT) or who have a specific genetic type of rectal cancer (dMMR/MSI-H).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with localized (non-metastatic) rectal cancer.
- You either have received or plan to receive total neoadjuvant therapy (TNT), OR you have a specific type of rectal cancer called dMMR/MSI-H (regardless of treatment).
- Your cancer has not spread to distant parts of the body at the time of diagnosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial analyzes biological and clinical information from people who have had surgery for rectal cancer since 2019. It aims to better understand rectal tumors, which may help improve future treatments.
This study looks at molecular (tumor biology) features of rectal cancer in people receiving standard short-course radiation. Your tissue and/or samples may be used to better understand the cancer and how it responds to treatment.
This study follows real-world treatment of locally advanced rectal cancer (cancer that has grown into nearby tissues but hasn't spread to distant organs) in patients who receive chemotherapy and/or radiation before surgery. Researchers track how different treatment approaches work to help improve outcomes.
This study looks at how rectal cancer responds to the usual chemotherapy and radiation given before surgery. It aims to learn if certain molecular features of your tumor can predict how well it responds to treatment.
This study asks people with rectal cancer to share their experiences in clinical trials. It may help researchers understand what patients go through, and could improve how future rectal cancer studies are designed.
This study is for people with rectal cancer who have had treatment like radiation or chemo and their tumor has disappeared or nearly disappeared. Instead of surgery right away, doctors will closely monitor the cancer with regular check-ups to make sure it stays gone.
Hear when a new Rectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.